Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -74.73% is 2256% below its 5-year average of -3.17%, near the low end of its 5-year range (-74.73%–6.64%).
As of the fiscal period ended Tuesday, June 30, 2026. 69.80% below its 12-month average of -44.01%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -74.73%.
RETURN ON INVESTED CAPITAL (ROIC)
-74.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-44.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-15.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-3.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-2.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-6.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-9.00%
CURRENT VS TTM AVG
-69.80%
CURRENT VS 3Y AVG
-386.52%
CURRENT VS 5Y AVG
-2256.16%
CURRENT VS 10Y AVG
-2704.09%
CURRENT VS 15Y AVG
-984.64%
CURRENT VS 20Y AVG
-730.07%
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-109.57%
vs the sector median at left
Vanda Pharmaceuticals Inc.
Market Cap
$271.81M
Return on Invested Capital (ROIC)
-74.73%
TTM Avg
-44.01%
3Y Avg
-15.36%
5Y Avg
-3.17%
Market Cap
$270.80M
Return on Invested Capital (ROIC)
-48.92%
TTM Avg
-66.11%
3Y Avg
-56.53%
5Y Avg
-47.58%
Market Cap
$266.92M
Return on Invested Capital (ROIC)
-58.72%
TTM Avg
-52.25%
3Y Avg
-49.23%
5Y Avg
-41.07%
Market Cap
$266.59M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-73.81%
3Y Avg
-69.44%
5Y Avg
-42.80%
Market Cap
$265.78M
Return on Invested Capital (ROIC)
-170.19%
TTM Avg
-56.97%
3Y Avg
-50.85%
5Y Avg
-45.83%
Market Cap
$264.25M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$280.37M
Return on Invested Capital (ROIC)
-61.10%
TTM Avg
-38.45%
3Y Avg
-31.16%
5Y Avg
-81.63%
Market Cap
$262.92M
Return on Invested Capital (ROIC)
-59.50%
TTM Avg
-188.11%
3Y Avg
-308.62%
5Y Avg
-250.56%
Market Cap
$281.54M
Return on Invested Capital (ROIC)
-27.62%
TTM Avg
-16.38%
3Y Avg
-32.77%
5Y Avg
-39.71%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | $271.81M | -74.73% | -44.01% | -15.36% | -3.17% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.80M | -48.92% | -66.11% | -56.53% | -47.58% |
| Fate Therapeutics, Inc. (FATE)vs › | $266.92M | -58.72% | -52.25% | -49.23% | -41.07% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $266.59M | -31.62% | -73.81% | -69.44% | -42.80% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | -170.19% | -56.97% | -50.85% | -45.83% |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | -61.10% | -38.45% | -31.16% | -81.63% |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | -59.50% | -188.11% | -308.62% | -250.56% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | -27.62% | -16.38% | -32.77% | -39.71% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | -42.92% | -30.10% | -80.25% | -64.52% |
ROIC
-74.7%
ROE
-124.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -74.73% |
| 2026-03-31 | -53.82% |
| 2025-12-31 | -45.00% |
| 2025-09-30 | -25.79% |
| 2025-06-30 | -20.73% |
| 2025-03-31 | -14.39% |
| 2024-12-31 | -7.31% |
| 2024-09-30 | -6.74% |
| 2024-06-30 | -5.80% |
| 2024-03-31 | -4.48% |
| 2023-12-31 | -1.37% |
| 2023-09-30 | -0.03% |
| 2023-06-30 | 1.12% |
| 2023-03-31 | 1.90% |
| 2022-12-31 | 0.65% |
| 2022-09-30 | 0.99% |
| 2022-06-30 | 2.07% |
| 2022-03-31 | 3.49% |
| 2021-12-31 | 6.35% |
| 2021-09-30 | 6.64% |
| 2021-06-30 | 6.32% |
| 2021-03-31 | 6.01% |
| 2020-12-31 | 4.30% |
| 2020-09-30 | 3.36% |
| 2020-06-30 | 5.38% |
| 2020-03-31 | 5.74% |
| 2019-12-31 | 5.35% |
| 2019-09-30 | 6.69% |
| 2019-06-30 | 7.46% |
| 2019-03-31 | 5.85% |
| 2018-12-31 | 7.75% |
| 2018-09-30 | 3.85% |
| 2018-06-30 | -0.24% |
| 2018-03-31 | -2.67% |
| 2017-12-31 | -12.51% |
| 2017-09-30 | -11.48% |
| 2017-06-30 | -8.24% |
| 2017-03-31 | -10.63% |
| 2016-12-31 | -11.60% |
| 2016-09-30 | -20.80% |
| 2016-06-30 | -27.75% |
| 2016-03-31 | -27.93% |
| 2015-12-31 | -24.85% |
| 2015-09-30 | 25.42% |
| 2015-06-30 | 29.41% |
| 2015-03-31 | 19.99% |
| 2014-12-31 | 12.24% |
| 2014-09-30 | -142.08% |
| 2014-06-30 | -127.94% |
| 2014-03-31 | -56.58% |
| 2013-12-31 | -18.46% |
| 2013-09-30 | -15.55% |
| 2013-06-30 | -22.53% |
| 2013-03-31 | -25.90% |
| 2012-12-31 | -27.35% |
| 2012-09-30 | -24.05% |
| 2012-06-30 | -20.25% |
| 2012-03-31 | -13.60% |
| 2011-12-31 | -7.09% |
| 2011-09-30 | -2.47% |
| 2011-06-30 | 0.02% |
| 2011-03-31 | 1.52% |
| 2010-12-31 | 3.77% |
| 2010-09-30 | -0.64% |
| 2010-06-30 | -5.15% |
| 2010-03-31 | -12.16% |
| 2009-12-31 | -18.51% |
| 2009-09-30 | -114.85% |
| 2009-06-30 | -111.85% |
| 2009-03-31 | -92.90% |
| 2008-12-31 | -113.59% |
| 2008-09-30 | -126.65% |
| 2008-06-30 | -131.35% |
| 2008-03-31 | -118.83% |
| 2007-12-31 | -95.19% |
| 2007-09-30 | -70.70% |
| 2007-06-30 | -51.32% |
| 2007-03-31 | -50.39% |
| 2006-12-31 | -241.98% |
| 2006-09-30 | -162.28% |
| 2006-06-30 | -111.54% |
| 2006-03-31 | -257.27% |
| 2005-12-31 | -78.77% |
